I n addition to its actions as a vasoconstrictor and neurotransmitter, serotonin (5-HT) is now recognized to be a cellular mitogen. [1] [2] [3] There is evidence that this mitogenic action is initiated by active transport via a cell surface transporter (SERT) of bovine, rat, and human pulmonary vascular smooth muscle cells (SMC). 1,4 -6 For other cells, the mitogenic action might be started through 1 or more of the cell surface receptors for 5-HT. A hierarchy of cell signaling responses occurs subsequent to ligation of the cell surface transporter or receptor. It has been well-established that these signaling responses include sequential activations of the small GTPase coupled protein, Rac-1, NADPH oxidase producing superoxide that is dismutated to H 2 O 2 , and extracellular signal-regulated kinase (ERK) 1/ERK2 MAP kinase. 2, [7] [8] [9] The small GTPase Rho A and its effector, Rho kinase (ROCK), also participate in cellular stress fiber formation and cell cycle progression. 10 -19 There has been limited study of the relationship of Rho A and ROCK to 5-HT. One study showed that Rho A bound to GTP is elevated in the rabbit aortic vascular ring preparation treated with 5-HT. 20 Another study suggested the activation of Rho A and ROCK in 5-HT-induced contraction of the bovine middle cerebral artery. 21 Serotonin participates in pulmonary hypertension, 5, 22, 23 and a polymorphism of the 5-HT transporter has been proposed to be involved in pulmonary hypertension in humans. 24 Because agents that block ROCK are currently available 25, 26 and may be useful in pulmonary hypertension, [27] [28] [29] we have undertaken an investigation of the potential participation of ROCK in pulmonary arterial SMC signaling and proliferation produced by 5-HT. The results of our study show that ROCK is activated by 5-HT and that its activation is essential for SMC proliferation produced by 5-HT. Furthermore, with the use of a chemical inhibitor of ROCK and a dominant negative mutant of Rho A, we found that neither the activation of ROCK nor that of ERK1/ERK2 by 5-HT is dependent on the other, but rather both pathways are required to produce cellular proliferation. Both upregulate cyclin D1, activate Elk, and cause DNA binding of Egr-1 and GATA-4, transcription factors that participate in the mitogenic action of 5-HT on SMC. ROCK activation appears to depend on ligation of 5-HT 1B/1D rather than SERT. Importantly, ROCK participates in proliferation by causing translocation of activated ERK1/ERK2 to the cellular nucleus. To our knowledge, this is the first demonstration that the translocation of ERK to the nucleus is dependent on ROCK for any mitogenic event.
Materials and Methods
SMCs from bovine pulmonary artery were cultured in RPMI-1640 medium containing 10% fetal bovine serum and antibiotics. Thymidine uptake was determined with growth-arrested SMC treated with 1 mol/L 5-HT, and supernatants of cell lysates were obtained for analysis. DN Rho A cDNA gene insertion was performed with adenoviral infections. Expressions of cyclin D 1 , Rho A, Erg-1, ERK, p-ERK, p-Elk, p MYPT1, and MYPT1 were analyzed with Western blots. Electrophoretic mobility shift assays were used to assess Egr-1 and GATA4. Immunochemistry was performed to localize intracellular ERK. F-actin stress fibers were visualized with a Zeiss fluorescent microscopy. Specific details regarding methodology and sources of materials used can be found in the online data supplement available at http://circres.ahajournals.org.
Results

5-HT Activates ROCK
We examined the effects of 5-HT on MYPT1, a myosin phosphatase binding subunit, which is inactivated by phosphorylation by ROCK. 25,30 -32 As shown in Figure 1A , 5-HT (1 mol/L) caused a transient phosphorylation of MYPT1, with a peak in 10 to 15 minutes. The effect of lysophosphosphatidic acid, a known activator of ROCK, is shown for comparison. [33] [34] [35] Inactivation of MYPT1 by 5-HT was inhibited by the ROCK inhibitor, Y27632, in a dose-dependent manner ( Figure 1B ). Bovine pulmonary artery SMC contain both SERT and a variety of 5-HT receptors, including the 5-HT1B/1D receptor as determined by polymerase chain reaction (unpublished data). We examined the influence of SERT and 5-HT receptor inhibitors on ROCK activity. Although inhibition of SERT had no influence on ROCK activation, GR55562 and GR127935, known 5-HT1B/1D receptor antagonists, blocked activation of ROCK by 5-HT (online Figure IA, IB) , and indicated that ROCK activation by 5-HT occurred via action on this receptor as opposed to SERT.
Role of ROCK in 5-HT-Induced Cell Growth
Treatment of cells with 5-HT caused an increase in thymidine incorporation that was inhibited in a dose-dependent manner by ROCK inhibitor Y27632 (Figure 2A) . Similarly, 5-HTmediated cyclin D1 expression was inhibited by pretreatment of cells with Y27632 ( Figure 2B ) and dominant negative Rho A ( Figure 2C ).
To further determine the role of ROCK in cell growth signaling mediated by 5-HT, we examined the effects of Y27632 on the activation of transcription factors that control cell mitogenesis. The E twenty-six domain transcription factor Elk-1 is a direct target of the MAP kinase pathway. 36 Phosphorylation of the Elk-1 transcriptional activation domain by MAP kinases triggers its activation. [37] [38] [39] Elk participates in responses to ERK1/ERK2 in cellular proliferation. 40 We found that treatment with 5-HT caused phosphorylation of Elk-1 of SMC (online Figure IIA) and that the activation is inhibited by Y27632 and U0126, inhibitors of ROCK and MEK, respectively (online Figure IIB) .
Egr-1 is a well-known immediate early response gene, which has been shown to regulate cellular proliferation in response to various growth factors. [41] [42] [43] We found that treatment of SMC with 5-HT-induced transient Egr-1 activation as monitored by electrophoretic mobility shift assays (online Figure IIC) . The Egr-1 activation by 5-HT requires the activation of both ERK and ROCK, because the induction of Egr-1 activity was blocked by pretreatment of cells with Y27632 or U0126 (online Figure IID) .
We recently reported that transcription factor GATA-4, another of the downstream effectors of ERK, plays a critical role in 5-HT signaling for SMC mitogenesis. 44 Thus, we examined the effect of Y27632 on GATA-4 activity. We found that although Y27632 had no effect on basal levels of GATA-4 activity, this ROCK inhibitor blocked 5-HT-induced upregulation of GATA-4 (online Figure IIE) . Taken together, these results indicate that the Rho A/ROCK path- 
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way plays a role in mitogenic signaling induced by 5-HT in pulmonary artery SMC.
Interactions Between ERK and ROCK Pathways
ERK has been shown to play an important role in 5-HTinduced mitogenesis of SMC. 1, 7 As noted, inhibition of ROCK diminished both cell proliferation and ERKdependent transcription factor activation induced by 5-HT in SMC. We therefore examined the effect of the ROCK/Rho A inhibitor Y27632 on 5-HT-induced ERK activation. 
ROCK Regulates ERK Translocation to the Nucleus
Activation of ERK occurs in the cytoplasm, but to exert many of its actions ERK must translocate into the nucleus. ERK has been shown to activate various transcription factors by translocating to the nucleus after being phosphorylated and activated in the cytosol. 45, 46 To further determine the signaling role of Rho A/ROCK in 5-HT-induced mitogenesis of SMC, we examined the effect of Y27632 on nuclear translocation of ERK induced by 5-HT. Treatment of SMC with 5-HT increased nuclear translocation of ERK as determined by Western blot analysis of nuclear-rich cellular fractions. As shown in Figure 5A , ERK nuclear translocation occurred transiently with a peak at 5 minutes, consistent with its phosphorylation. This induction of ERK nuclear translocation by 5-HT was completely abrogated by pretreatment of cells with Y27632 ( Figure 5B ). U0126, which blocks ERK activation, also caused a similar inhibition of the translocation to the nucleus. To confirm the experiments using nuclear-rich fractions, we performed immunohistochemistry using ERK antibody to directly visualize the ERK nuclear translocation. As shown in Figure 5C , in untreated cells, much of the ERK signal was dispersed in the cytosolic space around the nucleus. Treatment of cells with 5-HT caused the ERK protein to move into the nucleus. This could be visualized as early as after 2 minutes of 5-HT treatment, persisted for 10 to 20 minutes, and completely ceased by 40 minutes. Almost all of the cells, which were treated with 5-HT for 5 minutes, showed that ERK translocated to the nucleus ( Figure 5C , third panel; Figure 5D , second panel). This dramatic translocation of ERK by 5-HT was not observed when cells were pretreated with U0126, DNRho A, or Y27632 ( Figure 5D ). These results demonstrate that ROCK regulates nuclear translocation of ERK in the 5-HT signaling mechanism for SMC mitogenesis.
To assess a possible role of the cellular cytoskeleton in the translocation of ERK1/ERK2 from the cytoplasm to the nucleus under the regulation of ROCK, we examined the 5-HT-induced translocation in the presence of cytochalasin D and latrunculin B, agents that depolymerize actin. Both cytochalasin D and latrunculin B blocked cellular proliferation but failed to influence ERK phosphorylation (online Figure IVA, IVB) or translocation of ERK1/ERK2 to the cellular nucleus (online Figure IVC) .
Discussion
Serotonin produces pulmonary vascular SMC proliferation in culture. 2, 3, 6 Although some studies implicate actions on 5-HT receptors in the proliferative process, [47] [48] [49] [50] others support a hypothesis that the mitogenic action of 5-HT on vascular SMC is associated with the 5-HT transporter (SERT). 1 We have performed extensive work demonstrating the participation of SERT in 5-HT-induced proliferation of bovine pulmonary artery SMC. 2,3,8,9 5-HT activates a NADPH oxidase to produce superoxide that rapidly dismutates to H 2 O 2 . This H 2 O 2 is responsible for activating the MAP kinase, ERK1/ ERK2. 7, 8 Although the precise mechanism by which this occurs is not known, it may involve oxidation and inactivation of a relevant MAPK phosphatase. [51] [52] [53] Activation of ERK is responsible for downstream actions that increase DNA binding of transcription factors, such as GATA-4, 44 Egr-1, and Elk-1, and enhance expression of factors important in cell cycling, such as cyclin D1. SERT is important in the production of hypoxia-induced pulmonary hypertension in experimental animals 4, 54, 55 and may participate in various forms of pulmonary hypertension in humans. 24 Rho A is a member of the Ras superfamily of GTP-binding proteins. It cycles between a GDP-bound inactive state and a GTP-bound active state, and has been found to participate in cell growth, cell transformation, and change in shape and actin organization. 11,13-15,56 -59 The best-known downstream effector of Rho A in SMC is ROCK. ROCK phosphorylates a 130-kDa myosin phosphatase targeting (MYPT) subunit, also known as myosin binding subunit (MBS), and concurrently inactivates a phosphatase. 60, 27 Rho A/ROCK has been implicated in hypoxia-induced and monocrotaline-induced pulmonary hypertension in experimental animal models. 28, 29, 61 Rho A and ROCK have been studied in plateletderived growth factor-BB-induced proliferation of systemic vascular SMC. 62 Despite the recognition that Rho A/Rho kinase participates in pulmonary hypertension, its role in SMC signaling processes that may contribute to the hypertension (such as SMC proliferation produced by 5-HT) has never been examined. 
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We have found that SMC proliferation, cyclin D1 expression, Elk activation, and DNA binding of the transcription factors, GATA-4 and Egr-1, are all dependent on activation of ROCK by 5-HT. Activation of ERK1/ERK2 MAPK by 5-HT is independent of activation of ROCK and, conversely, activation of ROCK by 5-HT is independent of activation of ERK1/ERK2. Of interest, our studies with SERT and 5-HT receptor inhibitors indicate that 5-HT 1B/1D receptors, but not SERT, may be responsible for the activation of ROCK by 5-HT. These observations raise the interesting question of whether SERT and a 5-HT receptor produce a combinatorial action in response to 5-HT to result in a mitogenic effect. This hypothesis is consistent with a requirement of the 5-HT1B receptor for development of hypoxia-induced pulmonary hypertension 63 and recent studies suggesting interactions between SERT and 5-HT receptors. 64 We initiated an examination of mechanisms by which Rho A/Rho kinase participates in the proliferative process produced by 5-HT. Although it has been recognized that growth factors promote rapid nuclear translocation of ERK1/ ERK2, 46, 65 and that cellular actions of MAPK on gene regulation require its entry into the nucleus, little is known about the specific process by which this occurs. We have found that translocation of ERK1/ERK2 to the nucleus with 5-HT stimulation requires the action of Rho A/Rho kinase, although its activation does not. ROCK is known to participate in cell adhesion and assembly of cellular stress fibers, 66 whereby altered nucleocytoplasmic trafficking of signaling molecules may occur. 67 Furthermore, a recent report showed that cellular stretch and actin cytoskeleton configuration participate in ERK translocation via Rho A activation in cellular caveolae. 68 Therefore, we undertook experimentation to determine whether the actin cytoskeleton might participate in the translocation of ERK we have observed. Although disruption of the cytoskeleton with cytochalasin D and latrunculin B blocked 5-HT-induced cell proliferation, ERK phosphorylation and translocation of ERK was unaffected by this treatment, indicating that translocation of ERK in our cells does not depend on an intact actin cytoskeleton.
Activation by 5-HT of the transcription factor Elk-1 is ROCK-dependent and ERK-dependent, providing supportive evidence that movement of ERK into the nucleus requires 
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ROCK activation. As a direct target of the MAP kinase pathways, transcription factor Elk-1 is known to be coupled to ERK entry into the nucleus. 69 Our studies show that in nuclei isolated from Y27632-pretreated SMC, the activating phosphorylation of Elk-1, which is catalyzed by ERK, was strikingly diminished (online Figure IIA , IIB) and correlated with a decrease in the abundance of activated ERK in the nuclei ( Figure 5 ). In contrast, Y27632 did not alter phosphorylation of ERK in the total cell lysate. Our data suggest that impaired translocation of activated ERK to the nucleus by inhibition of ROCK is responsible for the decreased Elk-1 phosphorylation in SMC. This is the first time to our knowledge that nuclear translocation of ERK has been reported to depend on Rho A/Rho kinase for 5-HT. There has been a report suggesting that ROCK-mediated signaling may be involved in ERKmediated p21
Cip/waf1 induction in PMA-induced proapoptotic TF-1 and D2 cells. 70 However, unlike the results of our studies, they report that upregulated ROCK signal interfered with nuclear translocation of ERK. The process we observed may be similar to that reported for cellular cytoplasm to nucleus translocation of serum response factor produced by exposure of tracheal SMC to serum, 71 which also requires Rho A/ROCK for the translocation. Also, it has been proposed previously that apoprotein D inhibits platelet-derived growth factor-BB-induced vascular SMC proliferation by prevention of phosphorylated ERK1/ERK2 movement to the nucleus. 72 From these studies, we hypothesize that Rho A and ROCK play an important role in SMC proliferation produced by 5-HT through an influence on translocation of ERK1/ERK2 to the cellular nucleus. A diagram showing this hypothesis is presented in Figure 6 . A polymerized actin cytoskeleton does not appear to participate in this translocation. The activation of ROCK by 5-HT is initiated through a 5-HT1B/1D receptor, suggesting a concerted action of SERT and 5-HT receptor(s) in cellular proliferation that is in need of further investigation. 
